ABT

SEC source: 0001104659-26-113291 · tm2626917-5_4seq1.xml · derivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,499

Underlying: Common Shares · 397 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-26-113287 · tm2626917-4_4seq1.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,331

Underlying: Common Shares · 333 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-26-113286 · tm2626917-3_4seq1.xml · derivative · entry 1

Conroy Kevin T · CIK 0001306119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 551

Underlying: Common Shares · 318 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-26-113280 · tm2626917-1_4seq1.xml · derivative · entry 1

Roman Michael F · CIK 0001577544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,166

Underlying: Common Shares · 381 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-26-113285 · tm2626917-2_4seq1.xml · derivative · entry 1

Ahuja Nita · CIK 0002102715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 771

Underlying: Common Shares · 318 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001306119-26-000009 · form4-09252026_090910.xml · nonDerivative · entry 1

Conroy Kevin T · CIK 0001306119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,230

SEC source: 0001644207-26-000012 · form4-09032026_100920.xml · nonDerivative · entry 2

MCCOY JOHN A. JR. · CIK 0001644207 · VICE PRESIDENT AND CONTROLLER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,549

SEC source: 0001644207-26-000012 · form4-09032026_100920.xml · nonDerivative · entry 1

MCCOY JOHN A. JR. · CIK 0001644207 · VICE PRESIDENT AND CONTROLLER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,576

SEC source: 0001805099-26-000008 · form4-09032026_100959.xml · nonDerivative · entry 1

Boudreau Philip P · CIK 0001805099 · EVP AND CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,784

SEC source: 0001612571-26-000011 · form4-08272026_090838.xml · derivative · entry 7

Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 246,963 shares

Expires 2028-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001612571-26-000011 · form4-08272026_090838.xml · derivative · entry 6

Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 151,869 shares

Expires 2027-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001612571-26-000011 · form4-08272026_090838.xml · nonDerivative · entry 4

Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 306,461

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $116.36, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001612571-26-000011 · form4-08272026_090838.xml · nonDerivative · entry 3

Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 486,758

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.09 to $116.08, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001612571-26-000011 · form4-08272026_090838.xml · nonDerivative · entry 2

Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 705,293

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001612571-26-000011 · form4-08272026_090838.xml · nonDerivative · entry 1

Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 458,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001867666-26-000013 · form4-08132026_090844.xml · nonDerivative · entry 2

Morrone Louis H. · CIK 0001867666 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Indirect · Profit Sharing Trust

Disclosed balance after: 0

SEC source: 0001867666-26-000013 · form4-08132026_090844.xml · nonDerivative · entry 1

Morrone Louis H. · CIK 0001867666 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,724

SEC source: 0001306119-26-000006 · form4-07012026_090707.xml · derivative · entry 1

Conroy Kevin T · CIK 0001306119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 231

Underlying: Common Shares · 231 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

SEC source: 0001385262-26-000019 · form4-07012026_100703.xml · derivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,022

Underlying: Common Shares · 432 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001577544-26-000010 · form4-07012026_090744.xml · derivative · entry 1

Roman Michael F · CIK 0001577544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,746

Underlying: Common Shares · 416 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001867666-26-000009 · form4-07012026_090726.xml · nonDerivative · entry 1

Morrone Louis H. · CIK 0001867666 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,574

SEC source: 0001879701-26-000008 · form4-07012026_090745.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,963

Underlying: Common Shares · 363 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0002102715-26-000006 · form4-07012026_090738.xml · derivative · entry 1

Ahuja Nita · CIK 0002102715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450

Underlying: Common Shares · 347 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0002075371-26-000009 · form4-06292026_090621.xml · nonDerivative · entry 1

Cushman Elizabeth C. · CIK 0002075371 · EVP, GC AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,013

SEC source: 0001385262-26-000017 · form4-06182026_090625.xml · nonDerivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,319

SEC source: 0001783147-26-000009 · form4-04292026_090456.xml · nonDerivative · entry 1

Moreland Mary K · CIK 0001783147 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Indirect · Profit Sharing Trust

Disclosed balance after: 17,159

F1 · balance_after: Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2026.

SEC source: 0000902132-26-000005 · form4-04282026_110450.xml · nonDerivative · entry 2

STARKS DANIEL J · CIK 0000902132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,751,103

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.43 to $93.04, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0000902132-26-000005 · form4-04282026_110450.xml · derivative · entry 4

STARKS DANIEL J · CIK 0000902132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,105

Underlying: Common Shares · 7,105 shares

Expires 2036-04-23

F4 · security: Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0000902132-26-000005 · form4-04282026_110450.xml · nonDerivative · entry 1

STARKS DANIEL J · CIK 0000902132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,741,103

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001294731-26-000004 · form4-04282026_110436.xml · derivative · entry 2

McKinstry Nancy · CIK 0001294731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,305

Underlying: Common Shares · 2,305 shares

Expires 2036-04-23

F2 · security: Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001294731-26-000004 · form4-04282026_110436.xml · nonDerivative · entry 1

McKinstry Nancy · CIK 0001294731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,010

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001306119-26-000004 · form4-04292026_120423.xml · nonDerivative · entry 1

Conroy Kevin T · CIK 0001306119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,737

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined by the Program).

SEC source: 0001385262-26-000012 · form4-04282026_110409.xml · nonDerivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,319

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001527742-26-000012 · form4-04282026_110406.xml · derivative · entry 2

O'Grady Michael · CIK 0001527742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,929

Underlying: Common Shares · 5,929 shares

Expires 2036-04-23

F2 · security: Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001527742-26-000012 · form4-04282026_110406.xml · nonDerivative · entry 1

O'Grady Michael · CIK 0001527742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,603

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001537286-26-000002 · form4-04282026_100406.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,344

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001577544-26-000006 · form4-04282026_110409.xml · nonDerivative · entry 1

Roman Michael F · CIK 0001577544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,764

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001640036-26-000004 · form4-04282026_100440.xml · nonDerivative · entry 1

Kumbier Michelle · CIK 0001640036 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001736637-26-000002 · form4-04282026_100459.xml · nonDerivative · entry 1

Babineaux-Fontenot Claire · CIK 0001736637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,603

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001787479-26-000003 · form4-04282026_100441.xml · nonDerivative · entry 1

McDew Darren W · CIK 0001787479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,678

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001879701-26-000006 · form4-04282026_100407.xml · nonDerivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,205

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0002102715-26-000004 · form4-04282026_100439.xml · nonDerivative · entry 1

Ahuja Nita · CIK 0002102715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,286

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001805099-26-000006 · form4-04272026_090443.xml · nonDerivative · entry 2

Boudreau Philip P · CIK 0001805099 · EVP AND CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 2,200

SEC source: 0001805099-26-000006 · form4-04272026_090443.xml · nonDerivative · entry 1

Boudreau Philip P · CIK 0001805099 · EVP AND CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · Profit Sharing Trust

Disclosed balance after: 9,276

F1 · balance_after: Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2026.

SEC source: 0001385262-26-000010 · form4-04022026_090447.xml · derivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,489

Underlying: Common Shares · 382 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001448074-26-000008 · form4-04022026_090418.xml · derivative · entry 1

Alpern Robert J · CIK 0001448074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,544

Underlying: Common Shares · 76 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001577544-26-000004 · form4-04022026_090414.xml · derivative · entry 1

Roman Michael F · CIK 0001577544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,283

Underlying: Common Shares · 367 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001879701-26-000004 · form4-04022026_090438.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,558

Underlying: Common Shares · 321 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0002102715-26-000002 · form4-04022026_090445.xml · derivative · entry 1

Ahuja Nita · CIK 0002102715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102

Underlying: Common Shares · 102 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

SEC source: 0001263312-26-000004 · form4-03252026_100352.xml · nonDerivative · entry 1

ORVILLE JACOB A · CIK 0001263312 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,493

F1 · shares: These shares represent a restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 2-year term, with 1/2 of the award vesting in any one year, beginning on March 23, 2027. The award includes the right to have shares withheld for tax purposes.